← FDA Drug Approvals (Drugs@FDA)

TACROLIMUS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PANACEA · Approved 2012-09-28

Drug application

FDA Application #

ANDA090802

Application type

Abbreviated New Drug Application (Generic)

Brand name

TACROLIMUS

Generic name

TACROLIMUS

Active ingredients

TACROLIMUS

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

PANACEA

Manufacturer

Jubilant Cadista Pharmaceuticals Inc.

First approval

2012-09-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown